RobertDelauneMD

Oncology • Maplewood, MN

Physician

Join to view full profile

Dr. Delaune is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Delaune's full profile

Already have an account?

Office
1580 Beam Ave
Maplewood, MN 55109
Phone+1 651-779-7978

Fax+1 651-779-7656
Is this information wrong?

Education & Training

University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Vanderbilt University Medical CenterResidency, Internal Medicine, 1991 - 1994
McGovern Medical School at UTHealthClass of 1991

Certifications & Licensure

MN State Medical License 1997 - 2024
WI State Medical License 1997 - 2007
TX State Medical License 1995 - 1998
TN State Medical License 1994 - 1995

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Top MD Consumers Checkbook

Clinical Trials

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15
Active, not recruiting
Phase 3
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy Start of enrollment: 2008 Jun 15
Completed
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
Terminated
Phase 3
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Start of enrollment: 2010 Jun 01
Completed
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

37 citations
Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer.
Guru Sonpavde, Ana Aparicio, Feng Zhan, Brittany North, Robert Delaune, Lawrence E. Garbo, Steven R. Rousey, Ralph E. Weinstein, Lianchun Xiao, Kristi A. Boehm, Lina A...> ;Urologic Oncology. 2011 Nov 1
44 citations
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome...
Sherry L. Wolf, Rui Qin, Smitha Menon, Kendrith M. Rowland, Sachdev P. Thomas, Robert Delaune, Diana Christian, Eduardo R. Pajon, Daniel Satele, Jeffrey L. Berenberg, ...> ;Journal of Clinical Oncology. 2010 Dec 10
Azacitidine for castration-resistant prostate cancer progressing on combined androgen blockade.
Sonpavde G, Aparicio AM, Delaune R, Garbo LE, Rousey SR, Weinstein RE, Williams A, Zhan F, Boehm KA, Asmar L, Von Hoff DD> ;J. Clin. Oncol.. 2008-05-20
14 citations
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
Scott H. Okuno, Robert Delaune, Jeff A. Sloan, Nathan R. Foster, Matthew J. Maurer, Marie Christine Aubry, Kendrith M. Rowland, Gamini S. Soori, Daniel A. Nikcevich, C...> ;Cancer. 2008 Apr 15
4 citations
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium
Thomas E. Hutson, Svetislava J. Vukelja, Daniel Atienza, Sanjay Awasthi, Robert Delaune, Margaret Deutsch, Philip Y. Dien, Thomas F. Gregory, Michael J. Kolodziej, Jos...> ;Investigational New Drugs. 2008 Jan 31
Gemcitabine and epirubicin in patients with malignant pleural mesothelioma (MPM): A North Central Cancer Treatment Group phase II study.
Okuno SH, Delaune R, Sloan J, Aubry M, Foster N, Rowland K, Mailliard J, Nikcevich D, Jett J, Bot B> ;J. Clin. Oncol.. 2005-06-01
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Abbott Northwestern HospitalMinneapolis, Minnesota
M Health Fairview St. John's HospitalSaint Paul, Minnesota
United HospitalSaint Paul, Minnesota
M Health Fairview Woodwinds HospitalSaint Paul, Minnesota

RobertDelauneMD

Dr. Delaune is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.